Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional, Prospective Observational Cohort Study to Investigate the Effectiveness and Sustained Disease Control of an Upadacitinib Therapy in Moderate to Severe Atopic Dermatitis Patients Over Two Years

NCT05139836 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05139836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional, Prospective Observational Cohort Study to Investigate the Effectiveness and Sustained Disease Control of an Upadacitinib Therapy in Moderate to Severe Atopic Dermatitis Patients Over Two Years
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
December 13, 2021
Completion date
September 30, 2027
Enrollment
634 (actual)
Sites
125

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis